Sale!

Immunohistochemistry ROS1 IHC Test

Original price was: $226.Current price is: $150.

-34%

The Immunohistochemistry ROS1 IHC Test is a specialized diagnostic procedure that detects ROS1 protein expression in cancer tissue samples. This advanced immunohistochemistry test plays a crucial role in identifying patients who may benefit from targeted therapies for non-small cell lung cancer and other malignancies. By analyzing tumor tissue samples preserved in formalin-fixed paraffin-embedded blocks, the test provides essential information for treatment planning. Patients with confirmed lung cancer diagnoses, particularly those with adenocarcinoma histology, should consider this test to determine eligibility for ROS1-targeted treatments. The test offers significant benefits including personalized treatment selection, improved therapeutic outcomes, and avoidance of ineffective therapies. Results are typically available within 5-7 days, providing timely guidance for clinical decision-making. The test is available for $150 USD, offering accessible biomarker testing for cancer patients across the United States.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Immunohistochemistry ROS1 IHC Test: Advanced Cancer Biomarker Detection

Understanding the ROS1 IHC Test

The Immunohistochemistry ROS1 IHC Test represents a cutting-edge diagnostic approach in precision oncology, specifically designed to detect ROS1 protein expression in cancer tissue samples. This sophisticated immunohistochemistry-based assay plays a pivotal role in modern cancer care by identifying patients who may benefit from targeted therapeutic interventions.

What Does the ROS1 IHC Test Measure?

The ROS1 IHC test specifically detects the presence and expression levels of the ROS1 (c-ros oncogene 1) protein in tumor tissue samples. This biomarker testing is crucial because:

  • Identifies ROS1 protein overexpression in cancer cells
  • Helps determine eligibility for targeted ROS1 inhibitor therapies
  • Provides essential information for personalized treatment planning
  • Supports clinical decision-making in advanced cancer management

Who Should Consider ROS1 IHC Testing?

This specialized test is particularly recommended for patients with:

  • Confirmed diagnosis of non-small cell lung cancer (NSCLC)
  • Advanced or metastatic lung adenocarcinoma
  • Patients being evaluated for targeted therapy options
  • Individuals with treatment-resistant lung cancer
  • Patients seeking comprehensive biomarker profiling

Clinical Indications and Symptoms

Patients experiencing persistent respiratory symptoms, unexplained weight loss, chronic cough, or those with confirmed lung cancer diagnoses should discuss ROS1 testing with their oncologist. Early biomarker identification can significantly impact treatment outcomes and quality of life.

Benefits of ROS1 IHC Testing

Choosing the ROS1 IHC test offers multiple advantages for cancer patients:

  • Personalized Treatment Selection: Identifies patients who may respond to specific targeted therapies
  • Improved Outcomes: Enables selection of more effective treatment regimens
  • Reduced Side Effects: Helps avoid ineffective treatments and their associated toxicities
  • Comprehensive Care: Provides essential information for multidisciplinary cancer management
  • Timely Results: Rapid turnaround supports prompt treatment initiation

Understanding Your Test Results

Your ROS1 IHC test results will be interpreted by experienced pathologists and oncologists:

  • Positive Result: Indicates ROS1 protein expression, suggesting potential response to targeted therapies
  • Negative Result: No significant ROS1 protein detection, guiding alternative treatment approaches
  • Equivocal Result: May require additional testing or clinical correlation

All results include detailed interpretation and clinical recommendations from our specialized oncology team.

Test Pricing and Availability

Test Name Discount Price Regular Price
Immunohistochemistry ROS1 IHC Test $150 USD $226 USD

Turnaround Time

  • Sample Acceptance: Daily by 6 PM
  • Block Samples: 5 days
  • Tissue Biopsy: 5 days
  • Tissue Large Complex: 7 days

Sample Requirements and Instructions

For accurate ROS1 IHC testing, please provide:

  • Tumor tissue in 10% formal-saline OR formalin-fixed paraffin-embedded block
  • Ship samples at room temperature
  • Include copy of Histopathology report
  • Provide biopsy site information and clinical history

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our nationwide network ensures accessible, high-quality cancer biomarker testing for patients everywhere.

Book Your ROS1 IHC Test Today

Take the next step in your cancer care journey with comprehensive ROS1 biomarker testing. Our experienced team of oncologists and pathologists are ready to provide you with the precise diagnostic information needed for optimal treatment planning.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your test or speak with our genetic counseling specialists.

Don’t wait to get the critical information you need for personalized cancer treatment. Contact us now to book your Immunohistochemistry ROS1 IHC Test and take control of your healthcare journey.